Balentine LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 187 filers reported holding IMMUNOGEN INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
Balentine LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q2 2020$2,000
-33.3%
395
-28.7%
0.00%
Q4 2018$3,000
-40.0%
5540.0%0.00%
Q3 2018$5,000
-58.3%
554
-70.9%
0.00%
-100.0%
Q4 2017$12,000
-20.0%
1,9020.0%0.00%0.0%
Q3 2017$15,000
-50.0%
1,902
-55.2%
0.00%
-66.7%
Q2 2017$30,000
+87.5%
4,2410.0%0.00%
+50.0%
Q1 2017$16,000
+77.8%
4,2410.0%0.00%
+100.0%
Q4 2016$9,000
-18.2%
4,2410.0%0.00%
-50.0%
Q3 2016$11,0004,2410.00%
Other shareholders
IMMUNOGEN INC shareholders Q3 2020
NameSharesValueWeighting ↓
Redmile Group, LLC 13,063,767$35,403,0001.04%
QVT Financial LP 1,375,900$3,442,0000.87%
Virtus ETF Advisers LLC 50,045$136,0000.29%
Fernwood Investment Management, LLC 187,000$507,0000.27%
PURA VIDA INVESTMENTS, LLC 524,600$1,422,0000.20%
Endurant Capital Management LP 184,440$500,0000.20%
Birchview Capital, LP 90,000$244,0000.15%
TWIN FOCUS CAPITAL PARTNERS, LLC 112,873$306,0000.14%
DLD Asset Management, LP 1,239,500$3,347,0000.12%
DLD Asset Management, LP 1,186,300$3,215,0000.12%
View complete list of IMMUNOGEN INC shareholders